Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 51Genitourinary 16Head & Neck 6Thoracic 4Dermatologic 4Gynecologic 3Tumor-Agnostic 2Breast 2Other solid neoplasm 1

Conditions

Melanoma 3Skin Neoplasms 1Carcinoma, Basal Cell 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 195aldesleukin 148Interleukin-2 110fludarabine phosphate 107trametinib 85Temozolomide 83fludarabine 81Dacarbazine 81dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Magnetic Resonance Spectroscopy 50Specimen Handling 49Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Electroporation × Dermatologic × Clear all
NCT04526730 2026-02-20

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
17 enrolled 11 charts
Dermatologic

Melanoma, Skin Neoplasms

NCT05046262 2021-09-16

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Bispebjerg Hospital

Phase 3 Unknown
25 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT01045915 2015-09-11

AMEP

Valerio Therapeutics

Phase 1 Terminated
5 enrolled
Dermatologic

Melanoma

NCT01764009 2015-09-11

AIMM

Valerio Therapeutics

Phase 1/2 Withdrawn
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡